Profile

Cover photo
Amarantus BioScience, Inc.
16 followers|4,419 views
AboutPostsPhotosVideos

Stream

 
Apple is now highlighting how its tablet can be used for more than just entertainment and content consumption. The company is now advertising "C3 Logix," an app designed to measure the health of athletes after a concussion. http://on.mash.to/Offn5F
In a new page on Apple's website, the company is advertising C3 Logix, an iPad app designed to measure the health of athletes after a concussion.
1
Add a comment...
 
Amarantus appoints Dr. Charlotte Keywood as Chief Medical Officer of it's therapeutics division. Dr. Keywood brings over 20 years of experience in the biopharmaceutical drug development industry. CEO Gerald Commissiong states "We believe this experience will be of great value to Amarantus as we prepare to continue the development of Eltoprazine into Phase 2b clinical trials." http://bit.ly/PYImvv
1
Add a comment...
 
"I used to be the athlete," said Allison Kasacavage. "Now I'm the girl with concussions." Kasacavage, 17, suffers daily with the aftereffects of concussions from soccer. Christina L. Master, a sports-medicine specialist and concussion researcher at the Children's Hospital of Philadelphia always believed young athletes recovered quickly from a concussion; she is now seeing this is not the case; and something needs to be done. http://bit.ly/1j4Nato
Hannah Thomas, 17, can't pinpoint the day she realized that she would never play soccer again, or when the teenage highs of proms and college acceptances became weighed down by meds, therapy, and...
1
Add a comment...
 
Amarantus appoints Robert Farrell J.D. as Chief Financial Officer; bringing over 20 years of healthcare, public company and CFO experience to the Company. "We expect 2014 to be a transformative year for Amarantus as we lay the groundwork for long-term shareholder value creation," states Mr. Farrell. http://bit.ly/1olB58Q
1
Add a comment...
 
The legal battle over NFL concussions is expected to heat up as a judge in Philadelphia weighs the fairness of the proposed $765 million settlement. http://abcn.ws/1o1lSJN
1
Add a comment...
Have them in circles
16 people
 
Twelve year old Devin Kerby is living daily with the effects of TBI from a major car crash she suffered at just 4 years old. Today, she does all she can to raise money for this "silent epidemic." http://bit.ly/OfeTfI
FLORENCE, Ala. (WHNT) - It's called the Silent Epidemic. Each year 100,000 people die from Traumatic Brain Injury, and 500,000 more are permanently disabled. But one young girl from Florence, livin...
1
Add a comment...
 
More than 5.4 million Americans are living with Alzheimer’s disease, and a new report by the Alzheimer’s Association shows women are hit especially hard. Women after the age of 60 are more likely to develop Alzheimer's than breast cancer, they are also at the "at the epicenter of caregiving for someone with Alzheimer’s.” Angela Geiger, Chief Strategy Officer of the Alzheimer’s Association hopes this report will help move Alzheimer's treatment to center stage. http://onforb.es/1j4OQ6n
They're more likely to get the disease and care for someone from it.
1
Add a comment...
 
Follow our LinkedIn page and join today’s conversation on the LymPro Test. https://www.linkedin.com/company/amarantus-biosciences
1
Add a comment...
 
In his new blog post CEO Gerald Commissiong details the Company's recent achievement of key milestones that Amarantus believes will add significant value to the commercialization of the LymPro Test. He also introduced the newest member of the Amarantus team, Paul Jorgenson as Head of Product Development. Read full blog here: http://bit.ly/1oiamd3
1
Add a comment...
 
Amarantus appoints Dr. Louis Kirby to Board of Advisors to assist the Company in the development and commercialization of the LymPro Test. Dr. Kirby is a Board certified neurologist who brings over 25 years of industry experience to Amarantus, including work as principal investigator on nearly 400 clinical trials, including drug and diagnostic trials in Alzheimer's disease and other neurodegenerative conditions. CEO Gerald Commissiong states, "We believe Dr. Kriby will add excellent insight into our development and marketing efforts as we move forward." http://bit.ly/1fGiJGe
1
Add a comment...
Story
Introduction
Amarantus BioSciences, Inc. is developing new treatments for Parkinson's and Traumatic Brain Injury.